ANNOUNCES STRATEGIC SUPPLY AGREEMENTS WITH SUPREME AND TWO OTHER ACMPR LICENSED PRODUCERS
Pure Global Cannabis Inc.'s (PURE.V) wholly owned subsidiary, PureSinse Inc., has signed definitive supply agreements with The Supreme Cannabis Company Inc. and two other reputable Access to Cannabis for Medical Purposes Regulations licensed producers, from which PureSinse has purchased various quantities of premium quality medical cannabis that meet the high-quality standard requirements of Pure.
These agreements represent a significant milestone for PureSinse, as it has now received the necessary product required to obtain a sales licence under the ACMPR, which is expected in Q3 2018.
Pure Global president and chief executive officer Malay Panchal stated: "Procuring adequate supply of quality cannabis is an important milestone for Pure as we approach our full market launch for serving medical cannabis patients across Canada within the next several months. We will continue to work with Supreme and several other premium quality ACMPR producers to execute phase I of our business model to initiate revenue generation as soon as possible."
About Pure Global Cannabis Inc.
Pure Global Cannabis is a vertically integrated growth-oriented life sciences cannabis company led by experienced pharma industry, horticultural and supply chain experts. The company's wholly owned subsidiary, PureSinse, is a licensed producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR) focused on producing premium-quality cannabis products for medical, wellness and future legal adult recreational use. The company is launching Canada's first multiponic cannabis farm -- a patent-pending system that is expected to produce several-fold greater yields over traditional methods, while reducing cost and eliminating pesticide and herbicide use.